ADCX CANCER TREATMENT FRAMEWORK
Live / Applied — Non-final action mailed (as of 01 Sept 2026)
What this means for you
Not registered yet, but its 10 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79451815
- Mark type
- Stylized text
- Filed
- 10 Mar 2026
Goods and services
- Class 005 — Pharmaceuticals: Drugs for medical purposes; anti-cancer drugs; anti-cancer preparations; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; pharmaceuticals; pharmaceutical drugs; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; sanitary preparations for medical purposes; dietetic preparations for medical purposes; adjuvants for medical purposes; antiseptics; medicinal products for human medical purposes; bacteriological preparations for medical purposes; bacteriological preparations for pharmaceutical use; biological preparations for medical purposes; chemicals for pharmaceutical use; chemical preparations for medical purposes; chemical preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; dietary substances for medical purposes; protein preparations for medical purposes; elixirs (pharmaceutical preparations); feed additives for medical purposes; in vitro diagnostic preparations for medical purposes; capsules for medical purposes; germicidal detergents; dietary supplements for medical purposes; pharmaceutical preparations; preparations for sterilization.
- Class 010 — Medical apparatus: Apparatus for the treatment of cancer; medical apparatus and instruments for administering pharmaceuticals; surgical, medical, dental and veterinary instruments and apparatus; surgical sutures; electromedical diagnostic instruments; analysers for medical purposes; apparatus for physical rehabilitation for medical purposes; diagnostic devices for medical purposes; medical instruments for therapeutic drug.
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the area of cancerous diseases; pharmaceutical products development; scientific and technological services and research in the field of chemistry, biotechnology, biopharmacy and medicine; preparation of biotechnological and biopharmaceutical analyses; development of new diagnostic methods; services in the field of developing new medicines, as included in this class; development of medical and veterinary preparations and medicines; biological research; chemical services; chemical laboratory services; conducting chemical analyses; conducting scientific research; research in the field of bacteriology; research in the field of chemistry; research and development services relating to new products for third parties; scientific research; medical research in the field of rare diseases; research and development in the pharmaceutical and biotechnology fields.
Owner
- Adcytherix SAS, XL
Prosecution history
- 17 Sept 2026 — REFUSAL PROCESSED BY IB
- 02 Sept 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 01 Sept 2026 — REFUSAL PROCESSED BY MPU
- 23 Jun 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 22 Jun 2026 — NON-FINAL ACTION WRITTEN
- 18 Jun 2026 — ASSIGNED TO EXAMINER
- 12 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Jun 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB